Table 2.

Mortality rates per treatment group

Mortality	Piperacillin/tazobactam	Amoxicillin+temocillin	P-value
Overall mortality	15 % [14/94]	13 % [13/98]	NS
Hospitalised in ICU	44 % [8/18]	28 % [5/18]	NS
ARDS	38 % [6/16]	36 % [5/14]	NS
Mortality due to pneumonia	11 % [10/94]	7 % [7/98]	NS
Hospitalised in ICU	33 % [6/18]	11 % [2/18]	NS
ARDS	25 % [4/16]	14 % [2/14]	NS

NS not significant, ICU intensive care unit, ARDS acute respiratory distress syndrome